From Our Writers

Health Canada says the cannabis industry has a generally high rate of compliance, having ordered just 15 product recalls — all due to mislabeled CBD and THC content — since legalizing in 2018.

Congressional Democrats have put forward legislation aimed at addressing systemic racial discrimination by police that includes a ban on no-knock warrants for drug-related crimes.

Canadian researchers suggest that certain cannabinoid extractions could help to quell an immune system response to the coronavirus that has proven fatal in some patients; the study was published as a pre-print, meaning it has not been peer-reviewed.

Cannabis supporters in Arkansas can now accept electronic signatures in their campaign to put the legalization question on November’s ballot.

Following a pattern of dispensary burglaries during last weekend’s unrest, California regulators have started pulling databases containing cannabis business information from public view.

The Law Enforcement Action Partnership has released recommendations for Congress, local authorities, and the Trump administration for enacting sensible police reforms.

Hawaii officials and some medical cannabis licensees have been accused of putting patients’ health at risk via vape cartridges that would be deemed unsafe in other state markets.

Oregon’s monthly cannabis sales surpassed $100 million for the first time since the state legalized adult-use cannabis in 2015.

FSD Pharma has received FDA permission to design and submit an application for a new trial using a synthetic cannabinoid-based drug in the treatment of COVID-19.

A recent industry rules update allows Illinois hemp producers to sell to licensed medical and adult-use cannabis processors.

California officials have lowered their estimated cannabis tax revenues in light of the coronavirus and its effects on the economy, particularly the unemployment rate.

Iowa’s Senate has approved expansions to the state’s medical cannabis program; the bill is now headed to the governor’s desk, where it is expected to be signed into law.

The DEA has requested and received permission to investigate and police people taking part in the ongoing protests over the death of George Floyd.

Florida MCBD is suing New York-based Columbia Care claiming a pattern of wrongful interference as Columbia worked to secure a Florida cannabis business license.

Harborside in California is continuing its challenge of the federal tax code 280E, which the company’s legal team says is unconstitutional and runs afoul of the 16th Amendment.

The Maine Cannabis Coalition is suing the state over its recent decision to remove residency requirements for cannabis licensees.

A recent survey suggests that cannabis companies with the highest-paid executives tended to underperform over the last year compared to the industry average.

A recent industry analysis found that Leafs By Snoop is the most recognizable cannabis brand, followed by Cheeba Chews and Marley Natural.

Washington cannabis regulators have adopted emergency rules banning vitamin E acetate in cannabis vapor products and aim to expand cannabis testing requirements.

CannTrust has had the licenses for one of its grow facilities reinstated after its federal licenses were suspended last year over multiple regulatory violations.

Protests over the police killing of George Floyd took place nationwide over the weekend; in California, cannabis dispensaries were wrecked and looted, including Cookies and several MedMen locations.

Hemp businesses are unlikely to receive coronavirus assistance from the USDA as the sector hasn’t suffered a 5% decline in prices.

A recent study published in the journal Pain found that CBD treatment for dogs with osteoarthritis was beneficial in 9 out of 10 cases.

Law enforcement must stop arresting people over low-level cannabis crimes under a new law in San Marcos, Texas.